Definium Therapeutics, Inc. ( DFTX) - Stock Earnings
DFTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
DFTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -67.3 million USD | — USD |
| 2025Q4 | -50.4 million USD | — USD |
| 2026Q1 | -77.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DFTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -95.7 million USD | — USD |
| 2024 | -108.7 million USD | — USD |
| 2025 | -183.8 million USD | — USD |
| 2026 Est. | — | — |
DFTX
Price: $34.24
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.0 billion